NEOQUiTT leads the bioresonance technologies by a wide margin with unique and unrivaled features...
NEOQUiTT receives frequency from the body (endogenous bioresonance) or bioactive substances (exogenous bioresonance), and uses it with continuously changing parameters that are modulated digitally. In other words, the device processes the frequency taken from the body and uses the energetic information taken from the nosodes (e.g. urine samples) or pathologic substances (allergens/toxins/addictive substances).
What makes NEOQUiTT unique is its fast and powerful impact in the field of bioresonance. Drawing upon our 15 years of experience in bioresonance and our unique technologies and uses for bioresonance in Turkey, we can safely say that NEOQUiTT has put us ahead of what we have been able to do so far.
Which frequency is used and how that frequency is used make a difference in the effectiveness of resonance therapies. The software is continuously updated, and the updates are shared with device owners FREE OF CHARGE (based on fixed deals). NEOSANTE's 17 years of experience and all innovations are shared with the users.
Registered to the medical device product monitoring system of Turkey (UTS), NEOQUiTT is classified as a "Medical device" and permitted to be used officially in hospitals and private clinics.
The effectiveness of QUiTT technologies lies in details. For instance, this device is able to self-calibrate, which is one of the key features of such devices. This function is unique to QUiTT.
The device is also capable of detecting the problems or changes in the energetic state of the treatment setting or the frequency of the patient, and halting the operation automatically (for safety).
QUiTT does not operate as plugged in the mains power source because the sensitive German engineering put into the production of this device highlights that bioresonance sessions should be done in a self-contained system closed to grid power.
The frequency range of QUiTT technologies is ahead of legacy bioresonance devices by a wide margin. However, frequencies above 1 Mhz which may be challenging for the system are avoided.
The true difference lies in the software of the device. The device's capability to process frequencies using the advanced German technology meets more than 15 years of experience of NEOClinics for unique bioresonance protocols designed for NEOClinics. The protocols can be defined as instructions for how to process different frequency ranges.
The NEOQUiTT software incorporates the experience we have built up since 2005. It is exclusive to NEOClinics, and more effective than what we have achieved using different devices so far.
After our years of intensive experimenting with any type of bioresonance and different resonance technologies since 2005, we started a search for creating a bioresonance device based on our own experience rather than what the German or different device manufacturers told us, which bore its first fruits in 2014.
In 2014, we combined the experience we accumulated until then with a Germany-based company with 25 years of experience in bioresonance devices. This is how the QUiTT technology was born in 2016, and showed us that even greater achievements were possible. QUiTT continues to improve further with three major updates released (and distributed to users for free) so far...
NEOQUiTT/QUiTT Compact are new, powerful and easy-to-use bioresonance technologies that were born in Turkey for a global user base as the combination of NEOClinics with the advanced technology from Germany.
The final and most sophisticated form of resonance...